Ixekizumab Improves Signs and Symptoms of Patients with Radiographic and Non-radiographic Axial Spondyloarthritis and Extra-articular Manifestation of Enthesitis Through 16 Weeks

Schett G, Van Den Bosch F, Baraliakos X, Sandoval D, Geneus V, Bolce R, Liu-Leage S, Kronbergs A, Mease P (2020)

Publication Type: Conference contribution

Publication year: 2020

Journal

Arthritis and Rheumatology Wiley

Publisher: WILEY

City/Town: HOBOKEN

Conference Proceedings Title: ARTHRITIS & RHEUMATOLOGY

Authors with CRIS profile

Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Eli Lilly and Company US United States (USA) (US) Ruhr-Universität Bochum (RUB) DE Germany (DE) University Hospital Ghent BE Belgium (BE)

How to cite

APA:

Schett, G., Van Den Bosch, F., Baraliakos, X., Sandoval, D., Geneus, V., Bolce, R.,... Mease, P. (2020). Ixekizumab Improves Signs and Symptoms of Patients with Radiographic and Non-radiographic Axial Spondyloarthritis and Extra-articular Manifestation of Enthesitis Through 16 Weeks. In ARTHRITIS & RHEUMATOLOGY. HOBOKEN: WILEY.

MLA:

Schett, Georg, et al. "Ixekizumab Improves Signs and Symptoms of Patients with Radiographic and Non-radiographic Axial Spondyloarthritis and Extra-articular Manifestation of Enthesitis Through 16 Weeks." Proceedings of the ARTHRITIS & RHEUMATOLOGY HOBOKEN: WILEY, 2020.

BibTeX: Download